This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Unspecified threat to breathing
VWXY20_UNSPE_THREAT_BREAT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
412 |
4. Check minimum number of eventsNone |
412 |
5. Include endpointsNone |
412 |
6. Filter based on genotype QC (FinnGen only) |
369 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 5
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- W75-W84
Similar endpoints
↥List of similar endpoints to
Unspecified threat to breathing
based on the number of shared cases.
Similar with more cases:
- Other external causes of accidental injury
- Accidents
- External causes of morbidity and mortality
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 369 | 244 | 125 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.06 |
| Median age at first event (years) | 44.81 | 42.09 | 50.12 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 385
- Matched controls
- 3850
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
W84
ICD-10 Finland
Unspecified threat to breathing
4503599627370496.0
307.7
382
*
T78.4
ICD-10 Finland
Allergy, unspecified
47.9
299.5
200
85
C01CA24
ATC
epinephrine; parenteral
28.7
250.4
216
164
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
58.2
178.0
103
24
T78.3
ICD-10 Finland
Angioneurotic oedema
61.9
139.6
79
16
XQ800
NOMESCO Finland
Prick test
9.5
80.0
113
161
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
7.1
62.3
116
221
H02AB06
ATC
prednisolone; systemic
4.2
40.5
258
1249
X57
ICD-10 Finland
Unspecified privation
11.6
38.2
41
39
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
13.8
34.5
33
26
X59
ICD-10 Finland
Exposure to unspecified factor
3.8
32.2
133
467
L50.0
ICD-10 Finland
Allergic urticaria
8.7
32.1
43
55
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
8.3
31.6
44
59
L50.9
ICD-10 Finland
Urticaria, unspecified
6.5
31.2
55
96
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.5
29.0
84
227
A92
ICPC
Allergy/allergic reaction NOS
6.6
28.5
49
83
J45.9
ICD-10 Finland
Asthma, unspecified
3.4
24.6
118
447
R06AE07
ATC
cetirizine; oral
3.0
24.0
234
1317
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
43.0
23.0
28
7
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
48.2
22.7
27
6
T18.1
ICD-10 Finland
Foreign body in oesophagus
33.4
21.8
28
9
L50.8
ICD-10 Finland
Other urticaria
8.5
21.2
28
35
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
20.5
206
1148
N03AX16
ATC
[U] pregabalin
3.0
19.4
113
472
N02AX02
ATC
tramadol; systemic, rectal
2.6
19.3
187
1015
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.5
19.0
39
78
L27.2
ICD-10 Finland
Dermatitis due to ingested food
8.6
19.0
25
31
J46
ICD-10 Finland
Status asthmaticus
7.5
18.9
28
40
X58
ICD-10 Finland
Exposure to other specified factors
3.0
18.2
98
390
R06.0
ICD-10 Finland
Dyspnoea
2.7
17.8
136
652
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.8
17.4
109
471
R03DC03
ATC
montelukast; oral
2.9
17.4
101
419
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.1
17.4
84
314
R06AX27
ATC
desloratadine; oral
2.5
17.4
168
900
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
3.9
17.2
56
162
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
17.1
116
521
H02AB07
ATC
prednisone; oral
3.3
16.9
72
249
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
16.9
132
637
R06.2
ICD-10 Finland
Wheezing
4.7
16.4
40
93
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
6.5
16.1
27
44
Z3231
NOMESCO Finland
Registered nurse
2.5
15.9
141
719
AA1AD
NOMESCO Finland
CT of head and brain
2.6
15.8
124
596
R02
ICPC
Shortness of breath/dyspnoea
3.1
15.6
77
290
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
15.5
124
602
R06AE09
ATC
levocetirizine; oral
2.9
15.3
88
361
Z51.6
ICD-10 Finland
Desensitization to allergens
13.2
15.1
26
21
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
15.1
107
489
T78.1
ICD-10 Finland
Other adverse food reactions, not elsewhere classified
37.6
14.6
18
5
J45.1
ICD-10 Finland
Nonallergic asthma
3.7
14.5
50
150
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.9
14.3
79
316
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
14.1
76
300
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
13.8
75
297
R03BA05
ATC
fluticasone; inhalant
2.6
13.8
104
487
R42
ICD-10 Finland
Dizziness and giddiness
2.6
13.8
104
487
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.4
13.6
36
89
J45.8
ICD-10 Finland
Mixed asthma
5.6
13.4
26
49
R06AX13
ATC
loratadine; oral
2.7
13.4
85
365
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
13.3
61
219
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
13.3
181
1094
R03BA02
ATC
budesonide; inhalant
2.5
13.3
102
481
R03AC02
ATC
salbutamol; inhalant
2.3
12.9
253
1764
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
134.2
12.5
13
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.3
12.2
133
729
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
12.1
75
317
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
12.1
81
356
G43.9
ICD-10 Finland
Migraine, unspecified
3.2
12.0
52
180
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
12.0
71
293
J01FF01
ATC
clindamycin; systemic
2.3
12.0
120
634
J45
ICD-10 Finland
Asthma
3.0
11.9
59
221
Z3229
NOMESCO Finland
Other healthcare associate professional
3.3
11.9
49
165
N03AX12
ATC
[U] gabapentin; oral
2.7
11.7
75
322
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
11.7
50
172
SPAT1104
SPAT
Monitoring of emergency patient
3.9
11.6
36
100
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.2
11.6
49
167
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
11.6
121
649
S06.0
ICD-10 Finland
Concussion
2.7
11.4
68
281
R51.80
ICD-10 Finland
Headache
2.3
11.3
101
507
R50.9
ICD-10 Finland
Fever, unspecified
2.5
11.2
86
402
SPAT1255
SPAT
Intravenous administration of medicine
3.9
11.2
34
93
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
10.6
25
56
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
10.6
102
527
Z2221
NOMESCO Finland
Medical doctor
2.2
10.6
127
717
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
10.4
79
367
XF600
NOMESCO Finland
Bloodpressure measurement
3.3
10.4
41
134
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.9
10.4
52
196
X12
ICD-10 Finland
Contact with other hot fluids
19.4
10.3
15
8
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
10.2
48
174
Z3226
NOMESCO Finland
Physiotherapist
2.3
10.2
88
433
R60.0
ICD-10 Finland
Localized oedema
2.8
10.2
57
228
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.6
10.1
35
105
R03BB04
ATC
tiotropium bromide; inhalant
3.1
10.1
44
153
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.7
10.0
33
96
R60.9
ICD-10 Finland
Oedema, unspecified
3.9
9.9
30
82
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
9.7
54
215
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.2
9.7
20
40
D06
ICPC
Abdominal pain localized other
2.8
9.5
52
205
WX002
NOMESCO Finland
Sedation and analgesia
2.4
9.5
76
361
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
9.4
86
433
G44.2
ICD-10 Finland
Tension-type headache
2.4
9.4
76
363
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.3
9.3
24
58
A02BC05
ATC
esomeprazole; systemic
2.0
9.3
157
995
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
9.3
58
245
R07.0
ICD-10 Finland
Pain in throat
2.8
9.3
48
184
N06AB06
ATC
sertraline; oral
2.4
9.2
71
331
W49
ICD-10 Finland
Exposure to other and unspecified inanimate mechanical forces
5.2
9.2
19
38
J30.0
ICD-10 Finland
Vasomotor rhinitis
5.2
9.2
19
38
R96
ICPC
Asthma
2.7
9.1
51
204
N02AA05
ATC
oxycodone; systemic
2.4
9.0
69
321
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.5
9.0
31
93
S89.9
ICD-10 Finland
Unspecified injury of lower leg
4.2
8.9
24
60
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.8
8.8
45
171
N06AX16
ATC
venlafaxine; oral
2.3
8.6
73
355
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.2
8.5
78
391
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
8.5
123
734
ZXD05
NOMESCO Finland
Urgent procedure
2.0
8.5
131
800
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
8.5
36
123
N05BA04
ATC
oxazepam; oral
2.0
8.4
117
688
S01
ICPC
Pain/tenderness of skin
3.7
8.4
27
77
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.0
8.4
24
63
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.5
8.2
20
46
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
8.2
42
160
J01MA02
ATC
ciprofloxacin; systemic
1.9
8.2
140
884
R06AX22
ATC
ebastine; oral
2.2
8.1
83
435
R03AK07
ATC
formoterol and budesonide; inhalant
2.1
8.0
96
534
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
8.0
31
100
J01FA06
ATC
roxithromycin; oral
1.9
8.0
150
974
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
8.0
69
338
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
7.9
180
1240
XQ899
NOMESCO Finland
Other assessment of skin
13.4
7.9
13
10
WQ000
NOMESCO Finland
Hyposensibilisation
13.4
7.9
13
10
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.4
7.9
56
251
R4190
NOMESCO Finland
Nutritional therapy
3.3
7.7
29
92
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.5
7.7
27
82
XQ820
NOMESCO Finland
Exposure to medicinal substance
25.6
7.6
10
*
A08
ICPC
Swelling
3.3
7.6
29
93
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.4
7.6
28
88
M54.3
ICD-10 Finland
Sciatica
3.4
7.6
28
88
XG410
NOMESCO Finland
Flow-volume spirometry
4.1
7.5
21
54
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
7.5
245
1874
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
7.5
83
447
J37.0
ICD-10 Finland
Chronic laryngitis
4.6
7.5
18
41
R01AD08
ATC
fluticasone; nasal
1.9
7.5
124
770
L20.0
ICD-10 Finland
Besnier prurigo
2.4
7.5
56
257
A02BC02
ATC
pantoprazole; systemic
1.8
7.5
247
1896
W79
ICD-10 Finland
Inhalation and ingestion of food causing obstruction of respiratory tract
81.6
7.4
8
*
W80
ICD-10 Finland
Inhalation and ingestion of other objects causing obstruction of respiratory tract
81.6
7.4
8
*
S01GX01
ATC
cromoglicic acid; ophthalmic
2.0
7.4
95
540
N03AE01
ATC
clonazepam; systemic
3.4
7.4
27
84
X27
ICD-10 Finland
Contact with other specified venomous animals
+∞
7.3
7
*
H53.1
ICD-10 Finland
Subjective visual disturbances
2.7
7.3
41
164
N05AH04
ATC
quetiapine; oral
2.0
7.3
91
513
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.8
7.2
36
135
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
7.2
87
484
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
6.8
7.2
17
26
W19
ICD-10 Finland
Unspecified fall
2.5
7.2
47
203
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.2
7.1
64
318
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
7.0
120
750
WX892
NOMESCO Finland
Monitored bed care
2.8
7.0
36
137
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
7.0
51
231
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
7.0
97
566
R00.2
ICD-10 Finland
Palpitations
2.5
7.0
44
186
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
7.0
48
212
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.4
7.0
25
77
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.1
6.9
29
99
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
6.3
6.8
17
28
M79.6
ICD-10 Finland
Pain in limb
1.8
6.8
179
1271
N02BF02
ATC
pregabalin; oral
2.9
6.8
33
122
R03AK08
ATC
formoterol and beclometasone; inhalant
3.3
6.7
25
79
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
6.7
48
216
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.1
6.7
28
95
R21
ICPC
Throat symptom/complaint
1.8
6.7
124
795
N06AB10
ATC
escitalopram; oral
1.9
6.6
99
591
XQ801
NOMESCO Finland
Intracutantest
12.5
6.6
11
9
Y34
ICD-10 Finland
Unspecified event, undetermined intent
12.5
6.6
11
9
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
10.3
6.6
12
12
G43.3
ICD-10 Finland
Complicated migraine
5.5
6.5
18
34
J01MA12
ATC
levofloxacin; systemic
2.1
6.5
67
350
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
6.5
39
161
M79.1
ICD-10 Finland
Myalgia
2.1
6.5
72
387
R11
ICD-10 Finland
Nausea and vomiting
2.4
6.5
48
219
R4110
NOMESCO Finland
Physiotherapy
1.9
6.4
108
669
A06AD11
ATC
lactulose; oral
2.3
6.4
50
233
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
6.4
58
288
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
6.4
29
103
SPAT1081
SPAT
Cardiorespiratory global assessment
3.7
6.4
20
56
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
6.4
85
488
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.7
6.4
221
1686
R03AC03
ATC
terbutaline; inhalant
2.2
6.4
59
296
T58
ICD-10 Finland
Toxic effect of carbon monoxide
18.4
6.3
9
5
SPAT1263
SPAT
Sampling
1.7
6.3
167
1183
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.8
6.3
19
52
N17
ICPC
Vertigo/dizziness
2.2
6.3
54
263
B01AB05
ATC
enoxaparin; parenteral
1.8
6.3
107
666
L01
ICPC
Neck symptom/complaint
2.0
6.3
77
430
R05
ICD-10 Finland
Cough
1.9
6.3
93
554
R13
ICD-10 Finland
Dysphagia
2.8
6.2
32
122
SPAT1301
SPAT
No procedures
1.8
6.2
120
775
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
6.2
89
524
SPAT1097
SPAT
Recording of ECG
2.3
6.2
50
237
C03CA01
ATC
furosemide; systemic
1.9
6.2
86
501
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
6.2
30
111
UJD02
NOMESCO Finland
Gastroscopy
3.2
6.2
24
78
M79.7
ICD-10 Finland
Fibromyalgia
3.5
6.1
21
63
R06.4
ICD-10 Finland
Hyperventilation
6.2
6.1
15
25
M54.5
ICD-10 Finland
Low back pain
1.7
6.0
145
997
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
27
31
9.29
21.79
1.2
1.3
7.49
1.08
u/ml
1.18
21
17
82
326
2.93
15.06
4.9
5.1
1.44
1.49
mmol/l
0.07
74
278
65
244
3.00
13.14
1.9
1.4
—
—
—
0
0
37
100
3.99
12.43
1.3
1.1
0.92
0.79
u/ml
0.11
32
55
59
217
3.03
12.33
3.7
5.8
24.31
23.96
mmol/l
0.46
59
217
141
795
2.22
12.02
2.5
2.1
0.78
1.21
mg/l
2.14
111
605
41
123
3.61
11.87
1.3
1.2
0.35
2.37
u/ml
1.47
35
72
36
104
3.72
11.01
1.2
1.1
2.96
2.30
u/ml
0.13
31
59
98
498
2.30
10.56
3.2
1.9
—
—
—
0
0
176
1123
2.04
10.55
5.0
3.2
—
—
—
0
0
47
169
3.03
10.17
2.8
3.8
0.62
0.61
%
0.12
47
169
161
1005
2.03
10.16
2.9
2.5
53.09
62.04
u/l
1.16
154
945
194
1295
2.00
10.12
12.5
10.4
1.16
1.18
inr
0.27
167
1064
64
277
2.57
9.76
10.1
9.1
1.38
1.30
mmol/l
0.28
64
271
75
358
2.36
9.25
3.2
1.8
—
—
—
0
0
77
372
2.34
9.23
3.1
1.8
—
—
—
0
0
213
1503
1.93
9.12
10.8
8.0
1.21
1.21
mmol/l
0.07
194
1319
248
1853
1.95
8.81
8.6
5.6
6.46
6.43
mmol/l
0.07
240
1723
13
8
16.75
8.61
1.1
1.3
0.06
0.86
u/ml
—
13
8
196
1364
1.89
8.57
9.6
7.7
1.21
1.21
mmol/l
0.60
186
1269
102
568
2.08
8.56
5.6
4.0
479.46
304.72
ng/l
0.28
65
377
167
1111
1.89
8.33
6.3
3.5
29.63
99.11
ng/l
0.60
101
668
95
520
2.10
8.32
4.4
3.0
4.54
3.21
e6/l
0.74
63
243
189
1317
1.85
8.08
5.8
5.2
35.84
36.70
g/l
1.32
182
1258
146
939
1.89
8.02
3.9
2.2
133.81
270.47
u/l
1.19
139
898
257
1979
1.90
7.92
12.2
9.9
4.25
3.99
e9/l
1.12
225
1730
65
316
2.27
7.62
11.9
10.3
0.68
0.96
mmol/l
0.26
57
263
144
936
1.86
7.56
2.1
1.8
—
—
—
0
0
123
763
1.90
7.45
4.4
3.7
824.67
939.58
ng/l
0.22
107
634
12
9
13.71
7.43
1.3
1.0
94.67
94.44
%
—
12
9
40
157
2.73
7.37
1.7
1.7
—
—
—
0
0
141
917
1.85
7.35
5.0
3.0
0.47
0.24
e6/l
0.64
113
658
80
433
2.07
7.14
3.0
2.5
21.62
23.98
%
0.87
74
412
86
481
2.01
7.01
2.9
2.4
2.41
2.37
g/l
0.33
77
446
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
62
3.70
6.97
4.4
11.0
0.28
0.38
iu/ml
0.80
14
38
156
1062
1.79
6.91
5.2
3.1
101.01
103.72
e6/l
0.01
131
793
63
319
2.17
6.66
12.6
10.2
12.01
12.80
kpa
0.65
58
305
63
319
2.17
6.66
12.6
10.2
5.08
5.15
kpa
0.18
58
304
20
56
3.71
6.40
1.2
1.4
—
—
—
0
0
20
56
3.71
6.40
1.2
1.4
—
—
—
0
0
93
555
1.89
6.21
4.4
2.9
0.90
0.99
e6/l
0.10
62
278
267
2160
1.77
6.14
6.9
4.3
1238.00
59.90
e6/l
—
5
30
45
205
2.35
6.10
1.6
1.6
—
—
—
0
0
113
721
1.80
6.09
3.8
2.5
9.92
7.11
e6/l
0.59
103
648
37
155
2.53
6.00
2.8
1.8
—
—
—
0
0
45
208
2.32
5.91
6.0
7.7
1.62
1.33
mmol/l
0.26
35
161
178
1308
1.67
5.69
2.3
1.9
91.35
95.73
pmol/l
0.65
98
670
49
241
2.18
5.55
6.7
7.1
5.10
5.09
kpa
0.04
49
232
228
1795
1.66
5.51
4.7
3.6
0.00
0.00
estimate
0.50
42
371
52
263
2.13
5.50
2.6
2.3
7234.47
5651.73
u/l
0.15
18
109
230
1826
1.64
5.28
4.9
3.7
0.00
0.01
estimate
0.50
40
350
228
1810
1.64
5.20
4.8
3.7
31.57
4.07
estimate
0.41
42
370
118
793
1.70
5.19
2.9
2.4
—
—
—
0
0
22
76
3.01
5.12
1.2
1.0
0.80
0.26
u/ml
0.35
17
29
23
82
2.92
5.07
2.4
3.0
0.42
2.35
index
1.97
12
49
75
444
1.86
5.07
1.7
1.7
1043.71
1178.19
nmol/l
0.64
62
344
60
332
1.96
4.97
2.8
2.3
34.52
30.48
u/l
0.53
50
269
287
2434
1.70
4.90
11.1
7.8
78.06
79.72
u/l
0.28
281
2312
27
108
2.61
4.82
2.6
1.8
—
—
—
0
0
291
2481
1.71
4.82
4.6
3.7
—
—
—
0
0
36
166
2.29
4.76
2.5
1.9
13.62
5.57
iu/ml
—
10
38
26
103
2.63
4.74
2.8
1.7
—
—
—
0
0
201
1572
1.58
4.69
3.4
2.8
—
—
estimate
—
0
0
289
2480
1.66
4.44
6.8
4.1
11.63
9.78
mm/h
1.61
280
2328
277
2352
1.63
4.44
4.0
3.3
42.90
39.72
u/l
0.35
267
2255
123
865
1.62
4.44
2.5
2.2
2.76
2.76
mg/l
0.01
112
757
28
119
2.46
4.44
1.4
1.3
3.74
3.06
u/ml
—
7
14
360
3311
2.34
4.30
29.1
13.9
19.44
20.87
mg/l
0.48
323
2686
23
92
2.60
4.13
1.3
1.3
—
—
—
0
0
336
3025
1.87
4.12
23.0
12.7
89.37
88.47
ml/min/173m2
0.29
305
2748
190
1503
1.52
3.99
2.6
2.6
73.48
74.42
nmol/l
0.19
180
1375
76
484
1.71
3.98
1.7
1.9
1.50
1.38
%
0.80
67
433
19
70
2.80
3.98
1.4
1.1
1.71
3.42
u/ml
1.29
14
31
65
397
1.77
3.94
2.0
3.3
4.12
6.78
umol/l
1.91
57
353
27
120
2.34
3.90
1.4
1.3
30.64
6.60
u/ml
—
7
23
21
83
2.62
3.87
2.5
2.2
—
—
—
0
0
7
8
8.88
3.78
1.9
2.8
13.43
13.71
umol/l
—
7
8
16
56
2.94
3.67
1.6
1.6
—
—
—
0
0
31
151
2.15
3.63
5.4
8.8
24.62
24.62
mmol/l
0.00
31
146
300
2655
1.59
3.48
5.7
4.5
14.77
14.56
pmol/l
0.72
285
2445
21
88
2.47
3.46
2.8
1.5
—
—
—
0
0
14
47
3.05
3.44
1.1
1.3
—
—
—
0
0
18
71
2.61
3.34
1.9
1.8
—
—
—
0
0
14
48
2.99
3.33
1.1
1.4
0.41
0.54
nmol/l
0.74
14
43
14
48
2.99
3.33
2.0
1.6
—
—
—
0
0
338
3092
1.76
3.33
7.0
5.4
1.66
1.84
mu/l
3.52
323
2902
27
130
2.16
3.27
3.2
3.2
179.26
174.58
%
0.10
27
125
32
165
2.02
3.25
1.9
1.4
—
—
—
0
0
7
11
6.46
3.20
2.3
1.4
—
—
—
0
0
115
851
1.50
3.17
1.8
1.6
19.84
20.45
nmol/l
0.20
104
736
216
1812
1.44
3.06
4.0
3.2
134.30
89.31
ug/l
0.43
206
1723
5
5
10.11
2.98
1.0
1.0
—
—
—
0
0
95
685
1.51
2.94
1.5
1.4
16.40
24.91
iu/ml
1.04
27
208
38
216
1.84
2.93
5.1
4.4
104.97
76.93
ng/l
0.60
33
199
17
70
2.49
2.92
1.4
1.2
2.22
1.63
u/ml
—
9
27
29
151
2.00
2.89
1.4
1.4
—
—
—
0
0
51
318
1.70
2.88
1.4
1.3
77.76
160.95
u/ml
0.90
15
130
26
130
2.07
2.88
1.7
1.7
23.30
7.55
u/ml
—
7
31
17
71
2.46
2.84
2.8
1.5
—
—
—
0
0
15
59
2.60
2.82
2.5
1.5
—
—
—
0
0
104
771
1.48
2.81
4.0
2.8
328.60
326.03
umol/l
0.10
95
688
329
3026
1.60
2.71
5.1
4.4
5.75
5.79
mmol/l
0.19
314
2818
9
25
3.66
2.59
1.1
1.0
—
—
—
0
0
11
36
3.11
2.58
1.0
1.1
—
—
—
0
0
8
20
4.06
2.58
2.9
3.5
406.63
844.95
u/ml
—
8
20
13
50
2.66
2.56
1.8
1.6
—
—
—
0
0
9
26
3.52
2.49
3.9
1.5
—
—
—
0
0
81
584
1.49
2.49
1.6
1.6
498.09
36008269.12
pmol/l
0.76
74
511
16
70
2.34
2.44
1.9
1.6
—
—
—
0
0
11
38
2.95
2.43
3.8
2.7
107.09
106.11
mmol/l
0.36
11
38
11
38
2.95
2.43
3.8
2.7
1.21
1.19
mmol/l
0.58
11
38
11
38
2.95
2.43
3.8
2.7
3.98
4.02
mmol/l
0.12
11
38
129
1020
1.40
2.42
1.5
1.4
3.41
1.57
u/ml
0.47
27
288
6
12
5.06
2.41
2.2
1.8
60.52
110.63
ug/l
—
6
12
12
46
2.66
2.38
1.4
1.8
—
—
—
0
0
24
126
1.96
2.36
1.2
1.3
—
—
—
0
0
11
39
2.87
2.36
1.5
2.0
—
—
—
0
0
51
337
1.59
2.32
4.3
4.3
32.03
31.41
%
0.16
39
226
11
40
2.80
2.29
1.0
1.1
—
—
—
0
0
28
158
1.83
2.24
3.1
2.2
35.79
40.47
u/l
0.75
28
145
27
151
1.85
2.22
1.4
1.3
6.10
1.65
u/ml
—
5
6
132
1063
1.37
2.18
3.9
3.1
2.33
2.36
mmol/l
1.45
122
983
14
61
2.34
2.17
3.3
1.3
—
—
—
0
0
7
19
3.73
2.16
1.1
1.2
—
—
—
0
0
10
36
2.82
2.15
2.2
1.8
—
—
—
0
0
17
82
2.12
2.10
1.0
1.1
8.62
15.35
au/ml
—
5
29
20
103
1.99
2.09
1.4
1.5
346.90
477.70
mg/l
1.64
20
98
96
745
1.38
1.97
2.5
2.4
—
—
—
0
0
10
39
2.60
1.95
1.0
1.1
—
—
—
0
0
5
11
4.59
1.94
1.4
1.0
8.80
11.73
u/l
—
5
11
5
12
4.21
1.83
2.6
3.2
128.40
118.25
%
—
5
12
5
12
4.21
1.83
8.0
1.2
17.60
15.50
u/l
—
5
12
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
23
3.08
1.80
1.1
1.2
—
—
—
0
0
8
29
2.79
1.80
2.6
1.9
—
—
—
0
0
8
29
2.79
1.80
2.6
1.9
—
—
—
0
0
8
29
2.79
1.80
1.0
1.0
—
—
—
0
0
8
29
2.79
1.80
2.6
1.9
—
—
—
0
0
6
18
3.37
1.75
2.7
3.4
78.00
165.22
nmol/l
—
6
18
54
386
1.46
1.74
1.8
2.1
—
—
—
0
0
63
464
1.43
1.74
1.9
2.2
—
—
—
0
0
18
96
1.92
1.73
1.2
1.3
—
—
—
0
0
7
24
2.95
1.73
2.0
3.0
—
—
—
0
0
5
13
3.88
1.72
2.2
1.5
—
—
—
0
0
5
14
3.60
1.62
6.4
6.1
—
—
—
0
0
87
686
1.35
1.61
2.3
2.2
—
—
—
0
0
36
241
1.54
1.59
1.1
1.0
—
—
—
0
0
16
85
1.92
1.57
1.3
1.3
—
—
—
0
0
310
2900
1.35
1.56
6.5
5.6
38.91
38.21
mmol/mol
0.56
293
2747
17
93
1.87
1.54
1.2
1.4
367.82
312.85
ug/g
0.71
11
51
5
15
3.36
1.53
1.2
1.0
—
—
—
0
0
18
101
1.82
1.51
3.6
1.9
0.77
3.89
ug/l
0.56
13
87
6
21
2.89
1.51
1.2
4.1
2218.33
1134.19
mg
—
6
21
373
3623
1.95
1.49
38.2
21.4
257.87
256.61
e9/l
0.16
368
3565
10
45
2.25
1.47
1.2
1.3
—
—
—
0
0
5
16
3.15
1.44
1.4
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
16
3.15
1.44
1.0
1.1
112.60
122.25
%
—
5
16
5
16
3.15
1.44
1.2
1.3
—
—
—
0
0
6
22
2.75
1.44
1.2
1.1
—
—
—
0
0
373
3626
1.92
1.43
38.1
21.3
4.52
4.52
e12/l
0.14
366
3558
7
29
2.44
1.40
20.7
10.8
0.62
0.66
mmol/l
—
7
29
79
628
1.32
1.38
1.4
1.4
3.38
8.97
u/ml
1.40
27
252
40
284
1.46
1.36
3.9
3.1
—
—
—
0
0
313
2951
1.32
1.35
4.3
3.9
1.26
1.24
mmol/l
0.14
296
2764
16
91
1.79
1.31
1.3
1.5
1.45
10.44
e6/l
0.60
11
64
6
24
2.52
1.31
1.2
1.4
—
—
—
0
0
5
18
2.80
1.29
2.6
1.9
—
—
—
0
0
5
18
2.80
1.29
2.6
1.9
—
—
—
0
0
5
18
2.80
1.29
2.6
1.9
—
—
—
0
0
5
18
2.80
1.29
2.6
1.9
—
—
—
0
0
10
48
2.11
1.29
1.1
1.1
98.20
95.69
%
—
10
42
8
35
2.31
1.27
1.4
1.5
—
—
—
0
0
99
822
1.28
1.25
4.6
3.4
1.02
1.02
kg/l
0.07
66
534
8
36
2.25
1.25
1.4
1.5
—
—
—
0
0
8
36
2.25
1.25
1.4
1.5
—
—
—
0
0
8
36
2.25
1.25
1.4
1.5
—
—
—
0
0
8
36
2.25
1.25
1.4
1.5
—
—
—
0
0
18
108
1.70
1.24
3.0
2.2
—
—
—
0
0
16
93
1.75
1.23
1.5
1.6
—
—
—
0
0
16
93
1.75
1.23
1.3
1.6
2.00
98.88
e6/l
0.80
11
68
72
575
1.31
1.23
3.4
2.5
2.42
2.44
mmol/l
0.51
59
515
5
19
2.65
1.22
1.2
1.1
—
—
—
0
0
115
976
1.25
1.21
4.6
3.6
0.00
0.01
estimate
0.80
38
355
5
20
2.52
1.15
2.0
1.2
284.80
730.12
u/l
—
5
20
7
30
2.36
1.13
3.7
3.8
—
—
—
0
0
5
21
2.40
1.09
1.4
1.6
80.40
70.00
umol/l
—
5
21
5
21
2.40
1.09
1.0
1.4
—
—
—
0
0
5
21
2.40
1.09
1.8
1.9
9.00
10.18
umol/l
—
5
21
330
3158
1.31
1.09
5.6
5.1
2.78
2.76
mmol/l
0.10
319
2976
7
32
2.21
1.08
1.0
1.2
—
—
—
0
0
354
3425
1.42
1.07
15.7
11.0
27.66
26.31
u/l
0.38
349
3345
326
3119
1.29
1.04
5.1
4.6
4.65
4.67
mmol/l
0.12
312
2949
9
46
1.98
1.04
1.3
1.2
—
—
—
0
0
122
1059
1.22
1.04
3.2
3.0
0.00
0.02
estimate
0.96
31
303
5
22
2.29
1.03
1.2
1.3
—
—
—
0
0
155
1381
1.20
1.01
4.3
3.4
0.00
0.03
estimate
1.22
29
317
7
35
2.02
1.00
1.3
1.5
—
—
—
0
0
7
36
1.96
0.97
1.3
1.2
—
—
—
0
0
40
304
1.35
0.97
7.6
6.7
—
—
—
0
0
6
29
2.09
0.89
1.8
1.1
161.17
110.52
pmol/l
—
6
29
11
64
1.74
0.87
1.1
1.1
128.73
114.73
%
0.60
11
59
8
44
1.84
0.86
1.4
1.3
—
—
—
0
0
14
88
1.61
0.85
1.5
1.6
146.60
141.41
au/ml
—
5
26
8
46
1.75
0.83
1.0
1.1
—
—
—
0
0
13
81
1.63
0.82
1.5
1.3
—
—
—
0
0
21
147
1.45
0.82
1.5
2.1
5.39
2.99
mg/l
0.76
15
111
323
3110
1.24
0.81
5.0
4.5
1.43
1.47
mmol/l
0.88
310
2928
147
1326
1.18
0.80
1.7
1.9
1.42
1.35
mmol/l
0.44
132
1151
13
82
1.61
0.79
1.6
1.7
—
—
—
0
0
7
38
1.86
0.74
1.3
1.2
—
—
—
0
0
7
38
1.86
0.74
1.3
1.2
—
—
—
0
0
7
38
1.86
0.74
6.1
1.8
9.14
10.50
mmol/l
—
7
38
11
68
1.64
0.72
1.1
1.1
—
—
—
0
0
5
26
1.93
0.71
1.4
1.5
—
—
—
0
0
7
43
1.64
0.67
1.3
1.2
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
89.24
164.89
iu/ml
—
5
28
15
103
1.47
0.66
2.9
2.0
—
—
—
0
0
26
200
1.32
0.62
1.3
1.5
0.33
0.30
mg/l
—
9
83
8
49
1.65
0.62
1.3
1.6
—
—
—
0
0
10
65
1.55
0.56
3.1
1.8
—
—
—
0
0
113
1026
1.14
0.55
4.2
3.4
8.10
8.23
mmol/l
0.10
100
884
6
38
1.59
0.54
1.0
1.2
—
—
—
0
0
30
241
1.27
0.54
2.7
2.5
77.60
70.64
ml/min/173m2
0.57
15
103
9
64
1.42
0.52
1.3
1.3
—
—
—
0
0
34
410
0.81
0.51
3.0
2.9
0.47
0.76
ug/l
3.99
18
235
19
144
1.34
0.51
1.0
1.1
0.86
0.86
g/l
0.01
19
144
31
253
1.25
0.50
4.9
4.7
12.27
8.83
ug/l
0.14
25
197
96
870
1.14
0.48
5.0
4.1
19.59
9.38
mg/mmol
0.72
73
546
15
196
0.76
0.44
2.1
2.3
41.87
48.27
u/ml
0.11
15
189
18
140
1.30
0.42
1.0
1.1
1.55
1.55
g/l
0.00
18
140
0
19
0.00
0.39
0.0
10.2
—
39.88
—
0
8
0
19
0.00
0.39
0.0
1.1
—
0.40
—
0
19
9
69
1.31
0.37
1.4
3.0
31.18
38.38
mg/l
—
9
63
9
69
1.31
0.37
1.4
3.0
27.10
26.76
mg/l
—
9
62
6
41
1.47
0.36
1.2
1.5
—
—
—
0
0
73
668
1.11
0.33
1.4
1.6
—
—
—
0
0
19
229
0.82
0.31
1.2
1.3
—
—
—
0
0
37
419
0.87
0.31
1.7
1.8
3.29
3.41
ratio
0.19
27
324
19
226
0.83
0.28
1.4
1.5
—
—
—
0
0
22
189
1.17
0.24
1.5
1.4
278.71
274.88
miu/ml
0.01
11
97
28
316
0.88
0.23
1.4
1.7
3.40
3.47
mmol/l
0.13
18
218
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
10
0.00
0.21
0.0
13.7
—
5.69
—
0
10
0
10
0.00
0.21
0.0
1.2
—
60.10
—
0
10
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
5.30
—
0
5
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
9
111
0.81
0.20
1.2
1.1
—
—
—
0
0
6
50
1.20
0.20
1.2
1.5
7.20
7.39
mmol/l
—
6
43
6
52
1.16
0.19
3.7
3.4
20.33
33.89
u/ml
—
6
52
14
120
1.17
0.16
1.5
1.5
58.86
51.56
ug/l
0.28
14
120
5
44
1.14
0.10
2.4
1.8
13.80
13.35
%
—
5
44
12
134
0.89
0.09
1.4
1.6
—
—
—
0
0
7
67
1.05
0.08
3.3
2.2
—
—
—
0
0
53
548
0.96
0.06
4.3
4.2
17.93
21.81
%
1.11
21
233
70
682
1.03
0.06
4.9
4.9
2.51
2.05
ug/l
0.34
62
615
13
140
0.93
0.04
1.5
1.8
—
—
—
0
0
16
150
1.07
0.04
1.4
1.4
—
—
—
0
0
19
180
1.06
0.04
1.5
1.5
0.99
0.95
ratio
0.26
11
116
19
180
1.06
0.04
1.5
1.5
1.05
1.23
ratio
0.57
11
116
17
162
1.05
0.02
1.8
1.7
—
—
—
0
0
25
256
0.97
0.00
1.5
1.4
21.16
21.33
iu/l
0.01
20
214
11
111
0.99
0.00
1.2
1.1
—
—
—
0
0
12
119
1.01
0.00
1.5
2.0
2.18
5.22
iu/l
—
5
50
18
177
1.02
0.00
1.5
1.5
—
—
—
0
0
19
193
0.98
0.00
1.5
1.6
53.99
62.30
ug/l
0.39
14
167
16
164
0.97
0.00
2.1
1.8
—
—
—
0
0
34
336
1.01
0.00
1.4
1.6
905.94
942.47
mu/l
0.12
28
290
0
5
0.00
0.00
0.0
1.0
—
2.36
—
0
5
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
21.2
—
9.42
—
0
6
8
80
1.00
-0.00
1.3
1.5
—
—
—
0
0
8
82
0.98
-0.00
1.3
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
18
180
1.00
-0.00
1.6
1.5
1.02
1.15
ratio
—
10
116
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_UNSPE_THREAT_BREAT – Unspecified threat to breathing
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).